If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated ...

Rare appendix cancer diagnoses have tripled among millennials and quadrupled in younger Gen X individuals, according to new ...

Gianna Moore fought a rare form of cancer, but didn't let it diminish her love for soccer. She is The Enquirer's 2025 Courage ...

Appendix cancer cases have tripled among Gen X and quadrupled among millennials compared to previous generations. We spoke to ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form.

If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine tumors, regardless of tumor site, grade or previous non-somato ...